HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenneth M Hargreaves Selected Research

Cytochrome P-450 CYP2E1 (CYP2E1)

9/2013Major blunt trauma evokes selective upregulation of oxidative enzymes in circulating leukocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenneth M Hargreaves Research Topics

Disease

29Pain (Aches)
01/2021 - 01/2002
23Hyperalgesia
06/2015 - 04/2000
16Inflammation (Inflammations)
11/2013 - 04/2000
5Hypersensitivity (Allergy)
01/2021 - 04/2009
5Thrombosis (Thrombus)
08/2020 - 07/2008
4Dental Pulp Necrosis
08/2020 - 03/2013
3Chronic Pain
01/2021 - 04/2009
3Neoplasms (Cancer)
01/2017 - 03/2011
3Wounds and Injuries (Trauma)
09/2013 - 07/2008
3Hemorrhage
06/2012 - 07/2008
2Peripheral Nervous System Diseases (PNS Diseases)
01/2021 - 01/2017
2COVID-19
05/2020 - 01/2020
2Infections
09/2017 - 01/2016
2Periapical Periodontitis (Apical Periodontitis)
04/2014 - 06/2007
2Facial Pain (Myofacial Pain)
10/2011 - 11/2006
2Periodontitis
11/2008 - 07/2007
2Pulpitis
07/2007 - 04/2003
1Tooth Discoloration
08/2020
1Burns
09/2013
1Migraine Disorders (Migraine)
10/2011
1Sarcoma (Soft Tissue Sarcoma)
03/2011
1Necrosis
02/2011
1Neuralgia (Stump Neuralgia)
04/2009

Drug/Important Bio-Agent (IBA)

7Capsaicin (Zostrix)FDA Link
05/2014 - 04/2000
5Linoleic Acid (Linoleate)IBA
11/2013 - 11/2009
4Nerve Growth Factor (NGF)IBA
06/2015 - 06/2004
4LipidsIBA
11/2013 - 11/2009
4EnzymesIBA
11/2013 - 09/2012
4Calcitonin Gene-Related PeptideIBA
10/2012 - 11/2003
4BradykininIBA
07/2011 - 06/2007
3Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
11/2013 - 09/2012
3Analgesics (Analgesic Drugs)IBA
11/2013 - 11/2009
3AntibodiesIBA
11/2013 - 11/2009
3Transient Receptor Potential ChannelsIBA
09/2011 - 04/2008
3CannabinoidsIBA
02/2009 - 10/2006
3Opioid Analgesics (Opioids)IBA
01/2009 - 09/2005
2CalciumIBA
05/2014 - 10/2012
2Ketoconazole (Nizoral)FDA LinkGeneric
11/2013 - 09/2012
2Biological ProductsIBA
03/2013 - 03/2013
2Serotonin (5 Hydroxytryptamine)IBA
10/2012 - 10/2011
2Freund's AdjuvantIBA
10/2012 - 09/2012
2Minocycline (Cyclops)FDA LinkGeneric
06/2012 - 07/2008
2Ciprofloxacin (Cipro)FDA LinkGeneric
06/2012 - 07/2008
2Metronidazole (Metric)FDA LinkGeneric
06/2012 - 07/2008
2D-Penicillamine (2,5)- EnkephalinIBA
02/2012 - 01/2009
2Adenylyl Cyclases (Adenylyl Cyclase)IBA
02/2012 - 07/2011
2ProlactinIBA
09/2011 - 02/2010
2NeuropeptidesIBA
08/2011 - 06/2004
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2011 - 01/2005
2Estrogen ReceptorsIBA
10/2010 - 04/2009
2Local AnestheticsIBA
07/2010 - 07/2007
2Arachidonic Acid (Vitamin F)IBA
01/2009 - 06/2007
2Cannabinoid Receptor AgonistsIBA
01/2008 - 10/2006
2(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
01/2008 - 10/2006
2Peptide Hydrolases (Proteases)FDA Link
06/2007 - 11/2006
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2021
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2021
1Biocompatible Materials (Biomaterials)IBA
08/2020
1Sodium Hypochlorite (Clorox)IBA
08/2020
1RNA (Ribonucleic Acid)IBA
03/2020
1Vinca AlkaloidsIBA
01/2017
1Pharmaceutical PreparationsIBA
01/2017
1capsazepineIBA
05/2014
1Cytochrome P-450 CYP2E1 (CYP2E1)IBA
09/2013
1Cytochrome P-450 CYP2C19IBA
09/2013
1Steroid 12-alpha-Hydroxylase (CYP8B1)IBA
09/2013
1human CYP2A7 protein (CYP2A7)IBA
09/2013
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2013
1rat Cyp3a23-3a1 proteinIBA
10/2012
1IsoenzymesIBA
10/2012
16'-guanidinonaltrindoleIBA
02/2012
1norbinaltorphimineIBA
02/2012
14- (alpha- (4- allyl- 2,5- dimethyl- 1- piperazinyl)- 3- methoxybenzyl)- N,N- diethylbenzamideIBA
02/2012
1(trans)-Isomer 3,4- Dichloro- N- methyl- N- (2- (1- pyrrolidinyl)- cyclohexyl)- benzeneacetamideIBA
07/2011
1Opioid Receptors (Opioid Receptor)IBA
07/2011
1Ion Channels (Ion Channel)IBA
03/2011
1Anti-Bacterial Agents (Antibiotics)IBA
02/2011
1Ointments (Pastes)IBA
02/2011
1Pemetrexed (MTA)FDA Link
11/2010
19-hydroxyoctadecadienoic acidIBA
11/2009
113-hydroxy-9,11-octadecadienoic acidIBA
11/2009
1LigandsIBA
04/2009
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
04/2009
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
04/2009
1PPAR alphaIBA
04/2009
1PPAR gammaIBA
04/2009
1delta Opioid Receptors (delta Opioid Receptor)IBA
01/2009
1EnkephalinsIBA
01/2009
1ProstaglandinsIBA
01/2009
1hydroxide ionIBA
11/2008

Therapy/Procedure

4Therapeutics
01/2016 - 02/2011
3Pain Management
01/2021 - 01/2002
3Regenerative Endodontics
08/2018 - 03/2013
2Dental Care
05/2020 - 01/2020
2Drug Therapy (Chemotherapy)
01/2017 - 07/2011
2Apexification
01/2016 - 04/2014
2Injections
06/2015 - 05/2014
2Bite Force (Occlusal Forces)
06/2007 - 05/2007
1Aftercare (After-Treatment)
08/2020
1Endodontics
09/2017